NCT04114461View on ClinicalTrials.gov

Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 6, 2019

Primary Completion Date

December 4, 2019

Study Completion Date

December 4, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

HL-TOF tab. 5mg

HL-TOF

DRUG

Xeljanz tab. 5mg

Xeljanz

Trial Locations (1)

Unknown

YANGJI Hospital, Seoul

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT04114461 - Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers | Biotech Hunter | Biotech Hunter